p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancerJinghui Liu, Xiaoqi Liu, Dana Napier et al.|Oncogene|2020Cited by 114
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cellsElia Farah, Xiaoqi Liu, Lijun Cheng et al.|Journal of Biological Chemistry|2019Cited by 69
Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancerXiaoliang Chen, Xiaoqi Liu, Yifan Kong et al.|The Prostate|2019Cited by 33